BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25854095)

  • 41. Using implementation intentions to increase attendance for cervical cancer screening.
    Sheeran P; Orbell S
    Health Psychol; 2000 May; 19(3):283-9. PubMed ID: 10868773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Cervical Cancer Prevention and Treatment Infrastructure in Belize.
    Neibart SS; Smith TA; Fang JH; Anderson T; Kulkarni A; Tsui J; Hudson SV; Peck GL; Hanna JS; Beer NL; Einstein MH
    JCO Glob Oncol; 2021 Aug; 7():1251-1259. PubMed ID: 34351814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optical technologies and molecular imaging for cervical neoplasia: a program project update.
    Buys TP; Cantor SB; Guillaud M; Adler-Storthz K; Cox DD; Okolo C; Arulogon O; Oladepo O; Basen-Engquist K; Shinn E; Yamal JM; Beck JR; Scheurer ME; van Niekerk D; Malpica A; Matisic J; Staerkel G; Atkinson EN; Bidaut L; Lane P; Benedet JL; Miller D; Ehlen T; Price R; Adewole IF; MacAulay C; Follen M
    Gend Med; 2012 Feb; 9(1 Suppl):S7-24. PubMed ID: 21944317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computer-managed call and recall for cervical screening: a typology of reasons for non-attendance.
    Elkind A; Eardley A; Haran D; Spencer B; Smith A
    Community Med; 1989 May; 11(2):157-62. PubMed ID: 2752723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of women who did not respond to screening for cervical cancer.
    Berrino F; Chiappa L; Oliverio S; Todeschin P; Turolla E; Vegetti P
    Tumori; 1979 Apr; 65(2):143-55. PubMed ID: 462566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing cervical and breast cancer training in Africa with e-learning.
    Fokom Domgue J; Dille I; Fry L; Mafoma R; Bouchard C; Ngom D; Ledaga N; Gnangnon F; Diop M; Traore B; Pande M; Kamgno J; Diomande MI; Tebeu PM; Lecuru F; Plante M; Dangou JM; Shete S
    Lancet Glob Health; 2023 Jan; 11(1):e28-e29. PubMed ID: 36521948
    [No Abstract]   [Full Text] [Related]  

  • 47. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
    Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P
    BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Predictors for Non-Adherence to Colposcopy among Women in an Underserved Community in Rural Southern Western Nigeria.
    Ajenifuja KO; Adepiti CA; Okunola TO
    Niger Med J; 2022; 63(1):22-28. PubMed ID: 38798963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
    Linde DS; Rasch V; Mwaiselage JD; Gammeltoft TM
    BMJ Open; 2019 Feb; 9(2):e024011. PubMed ID: 30819704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South Africa.
    Moodley N; Gray G; Bertram M
    Clin Res HIV AIDS; 2016; 3(1):. PubMed ID: 28824960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.
    Finocchario-Kessler S; Wexler C; Maloba M; Mabachi N; Ndikum-Moffor F; Bukusi E
    BMC Womens Health; 2016 Jun; 16():29. PubMed ID: 27259656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis.
    Schnippel K; Michelow P; Chibwesha CJ; Makura C; Lince-Deroche N; Goeieman B; Mulongo M; Jordaan S; Firnhaber C
    BMC Health Serv Res; 2015 Nov; 15():499. PubMed ID: 26545585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
    Batra P; Kuhn L; Denny L
    S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature.
    Lester H; Wilson S
    Br J Gen Pract; 1999 Mar; 49(440):223-9. PubMed ID: 10343430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer.
    Savard J; Miller SM; Mills M; O'Leary A; Harding H; Douglas SD; Mangan CE; Belch R; Winokur A
    Psychosom Med; 1999; 61(4):496-507. PubMed ID: 10443758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Audit of cervical cancer screening and colposcopy attendance in rural South Africa.
    Knegt Y
    Afr J Reprod Health; 2014 Dec; 18(4):70-8. PubMed ID: 25854095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
    Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
    S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.